When contacted, Amit Mookim general manager (South Asia), IQVIA, said, "Indian pharmaceutical market has been clocking double-digit growth figures for the past three MAT periods. However, the market has been impacted by multiple developments in 2017 giving it a subdued annual growth.
Read more: GST, demonetisation disrupt domestic retail pharma market, growth may drop to single-digit in ...